These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 8607396)

  • 41. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrophysiology and long-term efficacy of pentisomide in patients with supraventricular tachycardia.
    Kühlkamp V; Mewis C; Seipel L
    Int J Cardiol; 1992 Jul; 36(1):69-79. PubMed ID: 1428255
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
    Honerjäger P; Schmidt G
    Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
    Nishino T
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].
    Vester EG
    Herz; 1997 Jun; 22 Suppl 1():40-50. PubMed ID: 9333591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
    Chazov EI; Rosenshtraukh LV; Shugushev KK
    Am Heart J; 1984 Sep; 108(3 Pt 1):483-9. PubMed ID: 6382989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of refractory supraventricular arrhythmias with flecainide acetate.
    Till JA; Rowland E; Shinebourne EA; Ward DE
    Arch Dis Child; 1987 Mar; 62(3):247-52. PubMed ID: 3105471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia].
    Brandão L; de Sousa J; Barreiros MC; Vagueiro MC; Amram SS
    Rev Port Cardiol; 1994 Mar; 13(3):197-202, 191. PubMed ID: 8049086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
    J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
    Haines DE; DiMarco JP
    J Am Coll Cardiol; 1990 May; 15(6):1345-54. PubMed ID: 2329238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P; Kattenbeck K; Heinroth KM; Ranke C; Trappe HJ
    Dtsch Med Wochenschr; 2000 Aug; 125(33):961-9. PubMed ID: 10994404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
    Chang KC; Lin YC; Chen JY; Chou HT; Hung JS
    Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
    J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sudden death of a horse with supraventricular tachycardia following oral administration of flecainide acetate.
    Dembek KA; Hurcombe SD; Schober KE; Toribio RE
    J Vet Emerg Crit Care (San Antonio); 2014; 24(6):759-63. PubMed ID: 25388866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
    Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term antitachycardia pacing experience for supraventricular tachycardia.
    den Dulk K; Brugada P; Smeets JL; Wellens HJ
    Pacing Clin Electrophysiol; 1990 Aug; 13(8):1020-30. PubMed ID: 1697949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Electrophysiologic effects of intravenous flecainide in intranodal junctional tachycardia in 30 patients].
    Haissaguerre M; Warin JF; Goldrach S; Le Métayer P; Guillem JP; Blanchot P
    Arch Mal Coeur Vaiss; 1988 Dec; 81(12):1493-8. PubMed ID: 3147639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
    Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.